Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
A Pillar Of Eisai’s Growth Strategy Misses Primary Endpoint In First Phase III Trial
Jan 11 2013
•
By
Daniel Poppy
More from Japan
More from Asia